Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study.

Park Y, Kim TJ, Hwang CS, Cho CH, Jeong DH, Seong SJ, Lee JK, Hur S, Kee MK, Seong J, Ki M.

J Gynecol Oncol. 2019 May;30(3):e50. doi: 10.3802/jgo.2019.30.e50.

2.

A case of an endobronchial metastasis from an endometrial carcinoma.

Lee CH, Kim HJ, Cho CH, Hwang I.

SAGE Open Med Case Rep. 2019 Jan 16;7:2050313X18823901. doi: 10.1177/2050313X18823901. eCollection 2019.

3.

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort.

So KA, Kim SA, Lee YK, Lee IH, Lee KH, Rhee JE, Kee MK, Cho CH, Hong SR, Hwang CS, Jeong MS, Kim KT, Ki M, Hur SY, Park JS, Kim TJ.

Obstet Gynecol Sci. 2018 Nov;61(6):662-668. doi: 10.5468/ogs.2018.61.6.662. Epub 2018 Oct 15.

4.

Cell Origins of High-Grade Serous Ovarian Cancer.

Kim J, Park EY, Kim O, Schilder JM, Coffey DM, Cho CH, Bast RC Jr.

Cancers (Basel). 2018 Nov 12;10(11). pii: E433. doi: 10.3390/cancers10110433. Review.

5.

BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea.

Kim DH, Cho CH, Kwon SY, Ryoo NH, Jeon DS, Lee W, Ha JS.

J Gynecol Oncol. 2018 Nov;29(6):e90. doi: 10.3802/jgo.2018.29.e90.

6.

Current medical treatment of uterine fibroids.

Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR; Working Group of Society of Uterine Leiomyoma.

Obstet Gynecol Sci. 2018 Mar;61(2):192-201. doi: 10.5468/ogs.2018.61.2.192. Epub 2018 Feb 13. Review.

7.

A retrospective comparison of outcome in IB2 and IIA cervical cancer patients treated with primary concurrent chemoradiation versus radical hysterectomy with or without tailored adjuvant therapy.

Jang TK, Shin SJ, Chung H, Kwon SH, Cha SD, Lee E, Shin C, Cho CH.

Obstet Gynecol Sci. 2017 Nov;60(6):549-557. doi: 10.5468/ogs.2017.60.6.549. Epub 2017 Oct 17.

8.

Targeted therapy of ovarian cancer including immune check point inhibitor.

Kim JY, Cho CH, Song HS.

Korean J Intern Med. 2017 Sep;32(5):798-804. doi: 10.3904/kjim.2017.008. Epub 2017 Aug 22. Review.

9.

A randomized controlled trial of physical activity, dietary habit, and distress management with the Leadership and Coaching for Health (LEACH) program for disease-free cancer survivors.

Yun YH, Kim YA, Lee MK, Sim JA, Nam BH, Kim S, Lee ES, Noh DY, Lim JY, Kim S, Kim SY, Cho CH, Jung KH, Chun M, Lee SN, Park KH, Park S.

BMC Cancer. 2017 May 2;17(1):298. doi: 10.1186/s12885-017-3290-9.

10.

Hsp90 inhibitor SY-016 induces G2/M arrest and apoptosis in paclitaxel-resistant human ovarian cancer cells.

Lee HG, Park WJ, Shin SJ, Kwon SH, Cha SD, Seo YH, Jeong JH, Lee JY, Cho CH.

Oncol Lett. 2017 Apr;13(4):2817-2822. doi: 10.3892/ol.2017.5794. Epub 2017 Mar 1.

11.

An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021).

Lee SW, Kim YM, Cho CH, Kim YT, Kim SM, Hur SY, Kim JH, Kim BG, Kim SC, Ryu HS, Kang SB.

Cancer Res Treat. 2018 Jan;50(1):195-203. doi: 10.4143/crt.2016.376. Epub 2017 Mar 21.

12.

Erratum to: Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.

Kim JE, Jang JS, Kim JW, Lee SY, Cho CH, Lee MA, Kim DJ, Ahn MJ, Lee KY, Sym SJ, Lim MC, Jung H, Kim CE, Min KW.

Support Care Cancer. 2017 May;25(5):1741. doi: 10.1007/s00520-017-3608-9. No abstract available.

PMID:
28197847
13.

Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell.

Lee HG, Shin SJ, Chung HW, Kwon SH, Cha SD, Lee JE, Cho CH.

J Gynecol Oncol. 2017 Mar;28(2):e14. doi: 10.3802/jgo.2017.28.e14. Epub 2016 Nov 14.

14.

Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.

Kim JE, Jang JS, Kim JW, Sung YL, Cho CH, Lee MA, Kim DJ, Ahn MJ, Lee KY, Sym SJ, Lim MC, Jung H, Cho EK, Min KW.

Support Care Cancer. 2017 Mar;25(3):801-809. doi: 10.1007/s00520-016-3463-0. Epub 2016 Nov 8. Erratum in: Support Care Cancer. 2017 May;25(5):1741.

PMID:
27826874
15.

Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.

Baik IH, Jo GH, Seo D, Ko MJ, Cho CH, Lee MG, Lee YH.

Int J Oncol. 2016 Nov;49(5):1953-1962. doi: 10.3892/ijo.2016.3688. Epub 2016 Sep 13.

PMID:
27633352
16.

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study.

So KA, Kim MJ, Lee KH, Lee IH, Kim MK, Lee YK, Hwang CS, Jeong MS, Kee MK, Kang C, Cho CH, Kim SM, Hong SR, Kim KT, Lee WC, Park JS, Kim TJ.

Cancer Res Treat. 2016 Oct;48(4):1313-1320. Epub 2016 Mar 9.

17.

New suturing technique for robotic-assisted vaginal cuff closure during single-site hysterectomy.

Shin SJ, Chung H, Kwon SH, Cha SD, Cho CH.

J Robot Surg. 2017 Jun;11(2):139-143. doi: 10.1007/s11701-016-0629-1. Epub 2016 Aug 23.

PMID:
27550318
18.

The effect of salinomycin on ovarian cancer stem-like cells.

Chung H, Kim YH, Kwon M, Shin SJ, Kwon SH, Cha SD, Cho CH.

Obstet Gynecol Sci. 2016 Jul;59(4):261-8. doi: 10.5468/ogs.2016.59.4.261. Epub 2016 Jul 13.

19.

Health-Related Quality of Life and Sociodemographic Characteristics as Prognostic Indicators of Long-term Survival in Disease-Free Cervical Cancer Survivors.

Kim MK, Sim JA, Yun YH, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, Park SY.

Int J Gynecol Cancer. 2016 May;26(4):743-9. doi: 10.1097/IGC.0000000000000665.

PMID:
26905329
20.

The Korean guideline for cervical cancer screening.

Min KJ, Lee YJ, Suh M, Yoo CW, Lim MC, Choi J, Ki M, Kim YM, Kim JW, Kim JH, Park EW, Lee HY, Lim SC, Cho CH, Hong SR, Dang JY, Kim SY, Kim Y, Lee WC, Lee JK.

J Gynecol Oncol. 2015 Jul;26(3):232-9. doi: 10.3802/jgo.2015.26.3.232.

Supplemental Content

Loading ...
Support Center